# A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

> **NCT01310322** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12 (estimated)

## Conditions studied

- Healthy
- Asthma

## Interventions

- **DRUG:** AZD5423
- **DRUG:** AZD5423
- **DRUG:** AZD5423
- **DRUG:** AZD5423

## Key facts

- **NCT ID:** NCT01310322
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01310322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01310322, "A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01310322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*